Selecting the optimal path to take your asset from promising molecule to manufactured compound may not always be as obvious as going from A to B. Dr Ross Burn, CEO and Dr Simon Tyler, COO at CatSci explain how process optimization can play an integral part in optimizing yield while reducing time and costs.   Pu ...

Charlie Johnson, CEO of ADC Bio, explains his company’s approach to process innovation for antibody drug conjugates, and the need for drug developers to create more efficient manufacturing processes.   The antibody drug conjugate (ADC) development industry must address and overcome the current industry challen ...

In the offshore oil and gas industry in the North Sea and North East Atlantic, regulation has been crucial in delivering health and safety to the work force. The question remains, however, whether it protects the marine environment.   In the UK sector, there are 18 primary legislative instruments1 in force, of ...